Limber Prosthetics, Inc. — SEC Form D Filing

Limber Prosthetics, Inc. filed an SEC Form D on August 18, 2026, reporting $135K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 18, 2026
Amount reported
$135K
Round stage
Seed
Industry
Medical Devices
Website
https://limberprosthetics.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Conventional prosthetic fabrication is time-consuming and inefficient, leading to limited access to prosthetic devices for many patients and a lack of significant technological advancement in the field. Existing prosthetics are often heavy, cumbersome, and not resilient enough for various daily activities.

Solution

Limber Prosthetics offers a digital workflow for O&P professionals to produce fully 3D-printed transtibial prostheses, such as the Px1, which are monolithic, lightweight, durable, and custom-designed for each patient, providing a more natural and versatile experience.

Why now

Advances in 3D printing technology, digital design, and materials science have made it possible to create highly customized, robust, and cost-effective prosthetics that were previously unachievable with traditional manufacturing methods.

Verdict

Investors saw a small, targeted entry into a niche ripe for modernization, not a scalable platform play. This cleared because it presented a tangible, incremental improvement in an underserved medical device workflow, addressing immediate clinician pain points. They were implicitly betting on the team's ability to execute a specialized manufacturing process and navigate regulatory pathways for a 3D-printed medical device. The limited upside stemmed from the highly specialized market size and the difficulty of broad adoption beyond early-mover prosthetists, rather than an unproven technology.

Source: SEC EDGAR Form D filing